A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.

Fibroblasts from a proband with Ehlers-Danlos syndrome type VII synthesized approximately equal amounts of normal and shortened pro alpha 2(I) chains of type I procollagen.Nuclease S1 probe protection experiments with mRNA demonstrated that the pro alpha 2(I) chains were shortened because of a deletion of most or all of the 54 nucleotides in exon 6, the exon that contains codons for the cleavage site for procollagen N-proteinase.Sequencing of genomic clones revealed a single-base mutation that converted the first nucleotide of intron 6 from G to A.Therefore, the mutation was a change, in the -GT-consensus splice site, that produced efficient exon skipping.Allele-specific oligonucleotide hybridizations demonstrated that the proband's mother, father, and brother did not have the mutation.Therefore, the mutation was a sporadic one.Analysis of potential 5' splice sites in the 5' end of intron 6 indicated that none had favorable values by the two commonly employed techniques for evaluating such sites.The proband is the fourth reported proband with Ehlers-Danlos syndrome VII with a single-base mutation that causes skipping of exon 6 in the splicing of RNA from either the COL1A1 gene or COL1A2 gene.No other mutations in the two type I procollagen genes have been found in the syndrome.Therefore, such mutations may be a common cause of the phenotype.The primers developed should be useful in screening for the same or similar mutations causing the disease.